would really appreciate any insights on which offers may be the best as i have been incredibly fortunate to get some offers
| +305 | I Snuck Into UBS Office And Took A Shit On The Floor | 28 | 1d |
| +291 | TPH V.S. Mizuho [HOU] | 36 | 2d |
| +248 | Houston 2026 Oil & Gas Investment Banking Rankings | 61 | 2h |
| +244 | Why leave restructuring for M&A? | 30 | 1d |
| +232 | Best Power/Renewables/Energy Teams? | 39 | 7h |
| +193 | Predicted 1Q 2027 Story - UBS IB blames Outlook Outage for Down Quarter | 36 | 11h |
| +187 | Centerview HC group falling off? | 30 | 1d |
| +184 | Actual EB List | 27 | 1d |
| +180 | Incoming TPH Analysts Larping as PWP on LinkedIn | 26 | 4h |
| +21 | What’s the current state of IBD at BofA? | 26 | 14h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Can you please share your level in IB? Are they all offering the same compensation?
for summer analyst, basically all same compensation
Gugg if your in the US, Roth if your in EU/UK
Gugg hasn’t been doing well, what makes you say go there?
Must have missed the Pfizer deal?
Gugg seems like it's doing just fine. Ranked somewhere around 27 last year (behind it's 2021 ranking of 18), but this year (super early) it was ranked something like 6th thus far.
It’s definitely group and location dependent but it you’re in the US, I’d go Guggenheim.
Group matters a lot - any more details? Without other info and assuming U.S., would go with Guggenheim
in us, guggenheim would be generalist, Piper Sandler is tech and would be interested on thoughts with their dbo acquisition, Lincoln is tmt
For your offer at Piper is it for SF or Burlingame? If its Burlingame then you would be working mainly on software deals while SF is pre-acquisition Piper's tech team.
Gugg 100%
Piper Sandler's Burlingame Tech team (DBO Partners) is very solid and I would definitely not discount them here. Their whole analyst class has historically been wharton/stanford/stern and they have regularly exited to UMM/MM PE. Guggenheim's TMT team is also very strong, but this matchup is a lot closer than you would think.
Lincoln is irrelevant compared to Gugg and Roth no matter what group or city you are in. Piper a little better but still think you should be deciding between Gugg and Roth
Bro what? For example, Lincoln stomps Industrials in the Midwest. It's not even remotely close. Different sports.
which offices have you received the offers at?
Gugg would get my vote.
Piper if you are really into MedTech or FIG
Guggenheim, easy decision even with their recent struggles. If you were in Europe then easy decision Rothschild.
Is Rothschild not close in the US?
very easy decision (if US) - it's guggs
Lincoln International has a really good culture. Wouldn't discount them.
Piper Sandler if you want to do Chemicals/FIG. Some would say Piper Medtech too but Guggenheim's HC team is definitely stronger if you want to do healthcare. IIRC, Gugg was on the Pfizer/Array deal a few years ago. A case can be made for Piper Tech if it's the Burlingame software team (DBO Partners) - a friend of mine took DBO over a mid-tier BB (CS/Citi) before Piper acquired them so would assume they are very solid. However, Guggenheim's TMT team is also one of their top groups on the street so would pick based on culture/people if looking at Tech. In terms of any other group (P&U, Retail, RX, O&G), would easily take Guggenheim. I personally wouldn't go Rothschild in the US when you have a top group at Guggenheim/Piper to choose from. Lincoln is decent, but would put them as last choice here. Reason is, I have a few friends at Lincoln who have noted that they do only marketing related tasks on the deals. Makes it very hard to go to MM/UMM PE from Lincoln when you do absolutely 0 modeling or analytical work.
Illo nulla quia tempore alias dolorem. Est repellat impedit nisi ex temporibus debitis velit. Quisquam repellendus totam ex velit possimus magni similique. Optio aut debitis qui natus illum. Et eaque quo quo. Est ut temporibus quia a magnam itaque dolorem.
Ab praesentium qui placeat non. In ratione quis quo velit incidunt. Corrupti voluptatum distinctio ea ullam praesentium qui. Aut ullam temporibus beatae non aut tenetur at. Eum eum necessitatibus libero temporibus ducimus sunt quisquam.
Tenetur non deserunt explicabo. Alias eum labore illo quo sunt ut. Et voluptatem impedit dolore qui est sed numquam rerum. Maxime culpa minus voluptates quas debitis. Ut quam natus porro temporibus hic.
Aut alias fugit vel aperiam. Reprehenderit deserunt accusamus eligendi perferendis architecto.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Natus accusantium atque sit ipsa tempora veritatis. Quibusdam quae aspernatur quis labore.